Protalix BioTherapeutics
PLX
#8665
Rank
A$0.20 B
Marketcap
$2.75
Share price
-0.57%
Change (1 day)
4.20%
Change (1 year)

Protalix BioTherapeutics (PLX) - Cash on Hand

Cash on Hand as of September 2024 : A$43.36 Million

According to Protalix BioTherapeutics 's latest financial reports the company has A$43.36 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Protalix BioTherapeutics - Cash on Hand chart (from 1999 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$65.4 M100.67%
2022-12-31A$32.59 M-39.39%
2021-12-31A$53.77 M7.27%
2020-12-31A$50.12 M97.26%
2019-12-31A$25.41 M-52.65%
2018-12-31A$53.66 M-18.11%
2017-12-31A$65.53 M-25.35%
2016-12-31A$87.78 M-16.26%
2015-12-31A$0.10 B56.66%
2014-12-31A$66.91 M-30.91%
2013-12-31A$96.86 M93.44%
2012-12-31A$50.07 M90.15%
2011-12-31A$26.33 M-25.49%
2010-12-31A$35.34 M-60.93%
2009-12-31A$90.46 M49.84%
2008-12-31A$60.37 M-14.61%
2007-12-31A$70.7 M142.8%
2006-12-31A$29.11 M349.42%
2005-12-31A$6.47 M789.03%
2004-12-31A$0.72 M-25.98%
2003-12-31A$0.98 M-31.32%
2002-12-31A$1.43 M-20.1%
2001-12-31A$1.79 M-37.62%
2000-12-31A$2.87 M28.63%
1999-12-31A$2.23 M6.17%
1998-12-31A$2.1 M150.4%
1997-12-31A$0.84 M-12.55%
1996-12-31A$0.96 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.39 B 811.22%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.94 B 4,380.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.74 B 36,209.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.25 B 12,009.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel